Akero Therapeutics Inc.

Insiders Updates

In a filing, Akero Therapeutics Inc revealed its Chief Development Officer Yale Catriona unloaded Company’s shares for reported $0.5 million

Insiders Updates

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Analysts Viewpoint

Akero Therapeutics Inc’s filing revealed that its President and CEO Cheng Andrew unloaded Company’s shares for reported $1.58 million on

Stock Earnings

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Stock Earnings

Akero Therapeutics Inc’s recent filing unveils that its Director Graham G. Walmsley acquired Company’s shares for reported $9.6 million on

Stock Earnings

Akero Therapeutics Inc’s filing revealed that its Chief Development Officer Yale Catriona unloaded Company’s shares for reported $3.01 million on

Tag: Akero Therapeutics Inc.